- Home
- RGTI vs ADMA Comparison
RGTI vs ADMA Comparison
Compare RGTI & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGTI
- ADMA
- Stock Information
- Founded
- RGTI 2013
- ADMA 2004
- Country
- RGTI United States
- ADMA United States
- Employees
- RGTI N/A
- ADMA N/A
- Industry
- RGTI Retail: Computer Software & Peripheral Equipment
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RGTI Technology
- ADMA Health Care
- Exchange
- RGTI Nasdaq
- ADMA Nasdaq
- Market Cap
- RGTI 3.7B
- ADMA 4.1B
- IPO Year
- RGTI N/A
- ADMA N/A
- Fundamental
- Price
- RGTI $8.32
- ADMA $21.31
- Analyst Decision
- RGTI Strong Buy
- ADMA Strong Buy
- Analyst Count
- RGTI 4
- ADMA 4
- Target Price
- RGTI $14.50
- ADMA $22.50
- AVG Volume (30 Days)
- RGTI 34.9M
- ADMA 3.7M
- Earning Date
- RGTI 05-08-2025
- ADMA 05-08-2025
- Dividend Yield
- RGTI N/A
- ADMA N/A
- EPS Growth
- RGTI N/A
- ADMA N/A
- EPS
- RGTI N/A
- ADMA 0.81
- Revenue
- RGTI $10,790,000.00
- ADMA $426,454,000.00
- Revenue This Year
- RGTI $32.30
- ADMA $18.45
- Revenue Next Year
- RGTI $139.90
- ADMA $26.96
- P/E Ratio
- RGTI N/A
- ADMA $26.31
- Revenue Growth
- RGTI N/A
- ADMA 65.16
- 52 Week Low
- RGTI $0.66
- ADMA $6.01
- 52 Week High
- RGTI $21.42
- ADMA $23.64
- Technical
- Relative Strength Index (RSI)
- RGTI 45.82
- ADMA 60.16
- Support Level
- RGTI $7.98
- ADMA $17.30
- Resistance Level
- RGTI $9.70
- ADMA $22.25
- Average True Range (ATR)
- RGTI 0.92
- ADMA 1.50
- MACD
- RGTI 0.06
- ADMA 0.16
- Stochastic Oscillator
- RGTI 50.69
- ADMA 83.62
About RGTI Rigetti Computing Inc.
Rigetti Computing Inc is engaged in the business of full-stack quantum computing. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, it derives a majority of its revenue from the United States.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.